Nantes, France, April 15, 2026 - 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...
Nantes, France, April 23, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company ...
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design ...
FireFly and Bellavista Resources Ltd (ASX: BVR) have obtained all necessary shareholder approvals for the sale of FireFly's Ontario gold assets to BellavistaAll conditions precedent required to be sat ...
CBSE is expected to announce the CBSE 12th result soon at cbse.gov.in and results.cbse.nic.in. Students can check scorecards, ...
Strong financial position supports ‘A’ ratings across life and annuity companies and underpins continued global expansion ...
The next phase of peace talks is uncertain after Iran says it has "no plans for the next round" of negotiations.
Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi ® /Minjuvi ® ) in first-line diffuse large b-cell lymphoma (DLBCL) will be ...
Under two different Illinois laws, people charged with sex offenses are subject to indefinite detention. Some people who’ve ...
Strong start of the year with Q1 2026 revenue up +13.6% in constant currencies. Revenue reaching € 51.0 million; +13.6% in constant currencies, in line with FY planned trajector ...
Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a pote ...
Iran swiftly reversed course on reopening the Strait of Hormuz after the U.S. said the move would not end its blockade.